openPR Logo
Press release

Biosimilar Market Size Expected to Reach USD 22550 Million by 2028 - Valuates Reports

03-01-2022 01:58 PM CET | Health & Medicine

Press release from: Valuates Reports

Biosimilar Market Size Expected to Reach USD 22550 Million

The Biosimilar market was valued at USD 9752.7 million in 2022, and it is anticipated to reach USD 22550 million by 2028, registering a CAGR of about 15.0% during the forecast period (2022-2028). Key drivers of the biosimilar market include the growing number of chronic diseases across the globe and the demand for biosimilars for their low costs.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biosimilar market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biosimilar market in terms of revenue.

Get Detailed Analysis of COVID-19 Impact on Biosimilar Market @ https://reports.valuates.com/request/sample/QYRE-Othe-0T469/Biosimilar_Market

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biosimilar market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biosimilar market.

Global Biosimilar Scope and Market Size

Biosimilar market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

View Full Report: https://reports.valuates.com/reports/QYRE-Othe-0T469/biosimilar

Key Market Players
➣Allergan plc
➣BIOCAD
➣Biocon
➣BioXpress Therapeutics
➣Boehringer Ingelheim
➣Celltrion
➣Coherus BioSciences
➣Dr. Reddy's Laboratories
➣Genor BioPharma
➣Intas Pharmaceuticals Limited
➣Novartis
➣Pfizer

By Type
➣Human Growth Hormones
➣Monoclonal Antibodies
➣Insulin
➣Peptides
➣Erythropoietin
➣Others

By Application
➣Oncology
➣Chronic and Autoimmune Diseases
➣Growth Hormone Deficiency
➣Infectious Diseases
➣Others

By Regional and Country-level Analysis
➣North America
➣United States
➣Canada
➣Asia-Pacific
➣China
➣Japan
➣South Korea
➣India
➣Southeast Asia
➣Australia
➣Rest of Asia-Pacific
➣Europe
➣Germany
➣France
➣U.K.
➣Italy
➣Russia
➣Nordic Countries
➣Rest of Europe
➣Latin America
➣Mexico
➣Brazil
➣Rest of Latin America
➣Middle East & Africa
➣Turkey
➣Saudi Arabia
➣UAE
➣Rest of MEA

Similar Reports:

Biopharmaceuticals Market: https://reports.valuates.com/market-reports/QYRE-Auto-22J2409/global-biopharmaceuticals

Cell Culture Media Market: https://reports.valuates.com/reports/QYRE-Auto-28A9340/cell-culture-media

Cell Culture Market: https://reports.valuates.com/reports/ALLI-Auto-1H413/cell-culture

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Valuates Reports
sales@valuates.com
For U.S. Toll Free Call +1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp : +91-9945648335

Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Linkedin - https://in.linkedin.com/company/valuatesreports
Facebook - https://www.facebook.com/valuatesreports/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilar Market Size Expected to Reach USD 22550 Million by 2028 - Valuates Reports here

News-ID: 2567285 • Views:

More Releases from Valuates Reports

Rice Husk-based Silica Market Size, Share & Forecast 2030 | Valuates Reports
Rice Husk-based Silica Market Size The global Rice Husk-based Silica market was valued at US$ 481 million in 2023 and is anticipated to reach US$ 795.7 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-36J13108/Global_Rice_Husk_based_Silica_Market_Research_Report_2023 Rice Husk-based Silica Market Trends Processing innovations refine the extraction process. Advanced calcination and acid leaching methods ensure minimal contamination, yielding silica suitable for high- performance applications like silicone rubber and specialty
Large Size Quartz Crucible (≥ 32 Inches) Market Surges as Solar Wafer Scaling …
Large Size Quartz Crucible (≥ 32 Inches) Market The global Large Size Quartz Crucible (≥ 32 Inches) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-23C17402/Global_Large_Size_Quartz_Crucible_32_Inches_Market_Research_Report_2024 Get Free Sample: By Type • 32 Inches • 36 Inches By Application • Semiconductor • Photovoltaic Key Companies Shin-Etsu Quartz Products, Momentive Technologies, JSQ, Ferrotec, Dunyuanjuxin Semiconductor Technology, OJing Science and Technology, MeiJing Material (Zhejiang), Ningxia
Quartz Crystal Microbalance (QCM) Biosensors Market Gains Momentum as Advanced R …
Quartz Crystal Microbalance (QCM) Biosensors Market The global market for Quartz Crystal Microbalance (QCM) Biosensors was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-19O11267/Global_Quartz_Crystal_Microbalance_QCM_Biosensors_Market_Research_Report_2022 By Type • Metal Sensors • Oxide Sensors • Carbide Sensors • Polymer Sensors By Application • University • Research institutions • Life Science Company Key Companies Biolin Scientific (Addlife), AWSensors, Quartz Pro, INFICON, MicroVacuum, 3T analytik, Gamry Instruments, Shenzhen
Quartz Glass for Semiconductor Market Expands as Advanced Chip Manufacturing Dri …
Quartz Glass for Semiconductor Market Size The global market for Quartz Glass for Semiconductor was valued at US$ 2341 million in the year 2024 and is projected to reach a revised size of US$ 3048 million by 2031, growing at a CAGR of 3.9% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-3K5456/Global_Quartz_Glass_for_Semiconductor_Market_Insights_Forecast_to_2028 By Type • Fused Quartz • Natural Quartz • Synthetic Quartz By Application • Semiconductor Industry Key Companies Pacific Quartz, Heraeus, CoorsTek, Tosoh, AGC, Corning, Shin-Etsu Quartz Products Co., Ltd., Raesch Quarz

All 5 Releases


More Releases for Biosimilar

Interchangeable Biosimilar Humira Market Share Driven by Biologic Therapy Adopti …
Interchangeable Biosimilar Humira Market The global market for Interchangeable Biosimilar Humira was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period View sample report https://reports.valuates.com/request/sample/QYRE-Auto-33I15005/Global_Interchangeable_Biosimilar_Humira_Market_Research_Report_2023 The Interchangeable Biosimilar Humira Market is experiencing significant market growth as healthcare providers and patients increasingly adopt biosimilar therapies for autoimmune and inflammatory conditions. Market trends indicate rising
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." Get
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031." The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Interested to know more about the functioning of